Synergistic effect of TIM4 and MFG-E8 null mutations on the development of autoimmunity

International Immunology

Volumn 24, Issue 9, 2012, Pages 551-559

  Miyanishi, Masanori ^a,c   Segawa, Katsumori ^a   Nagata, Shigekazu ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autoimmune disease; Engulfment; Macrophages; Pristane; TNF

Indexed keywords

AUTOANTIBODY; INTERFERON; LACTADHERIN; MEMBRANE PROTEIN; PROTEIN TIM4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GENE MUTATION; MFG E8 GENE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TIM 4 GENE;

AGE FACTORS; ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON TYPE I; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MILK PROTEINS; NEUTROPHILS; PHOSPHATIDYLSERINES; SEQUENCE DELETION; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865559140     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs064     Document Type: Article

References (47)

1. Nagata, S., Hanayama, R. and Kawane, K. 2010. Autoimmunity and the clearance of dead cells. Cell 140:619.
2. Palis, J. 2008. Ontogeny of erythropoiesis. Curr. Opin. Hematol. 15:155-161.
3. Gaipl, U. S., Kuhn, A., Sheriff, A. et al. 2006. Clearance of apoptotic cells in human SLE. Curr. Dir. Autoimmun. 9:173.
4. Munoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A. and Herrmann, M. 2010. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6:280.
5. Yoshida, H., Kawane, K., Koike, M., Mori, Y., Uchiyama, Y. and Nagata, S. 2005. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 437:754.
6. Gardai, S. J., Bratton, D. L., Ogden, C. A. and Henson, P. M. 2006. Recognition ligands on apoptotic cells: a perspective. J. Leukoc. Biol. 79:896.
7. Rothlin, C. V. and Lemke, G. 2010. TAM receptor signaling and autoimmune disease. Curr. Opin. Immunol. 22:740.
8. Park, S. Y., Jung, M. Y., Kim, H. J. et al. 2008. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 15:192.
9. Park, D., Tosello-Trampont, A. C., Elliott, M. R. et al. 2007. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/ Dock180/Rac module. Nature 450:430.
10. Hanayama, R., Tanaka, M., Miwa, K., Shinohara, A., Iwamatsu, A. and Nagata, S. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417:182.
11. Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T. and Nagata, S. 2007. Identification of Tim4 as a phosphatidylserine receptor. Nature 450:435.
12. Miyasaka, K., Hanayama, R., Tanaka, M. and Nagata, S. 2004. Expression of milk fat globule epidermal growth factor 8 in immature dendritic cells for engulfment of apoptotic cells. Eur. J. Immunol. 34:1414.
13. Wong, K., Valdez, P., Tan, C., Yeh, S., Hongo, J. and Ouyang, W. 2010. Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages. Proc. Natl. Acad. Sci. USA 107:8712.
14. Hanayama, R., Tanaka, M., Miyasaka, K. et al. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304:1147.
15. Rodriguez-Manzanet, R., Sanjuan, M., Wu, H. et al. 2010. T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc. Natl. Acad. Sci. USA 107:8706.
16. Kawane, K., Fukuyama, H., Yoshida, H. et al. 2003. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 4:138.
17. Ray, S. and Diamond, B. 1994. Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis. Proc. Natl. Acad. Sci. USA 91:5548.
18. Abrams, J. S., Roncarolo, M. G., Yssel, H., Andersson, U., Gleich, G. J. and Silver, J. E. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
19. Shiraishi, T., Suzuyama, K., Okamoto, H. et al. 2004. Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif. Biochem. Biophys. Res. Commun. 322:197.
20. Ledermann, B. and Burki, K. 1991. Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp. Cell Res. 197:254.
21. Lee, P. Y., Kumagai, Y., Li, Y. et al. 2008. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J. Exp. Med. 205:2995.
22. Kawane, K., Ohtani, M., Miwa, K. et al. 2006. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998.
23. Watanabe, T., Yoshida, M., Shirai, Y. et al. 2002. Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver. J. Immunol. 168:2188.
24. Fukuyama, H., Adachi, M., Suematsu, S. et al. 2001. Requirement of Fas expression in B cells for tolerance induction. Eur. J. Immunol. 32:223.
25. Nakayama, M., Akiba, H., Takeda, K. et al. 2009. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113:3821.
26. Asano, K., Miwa, M., Miwa, K. et al. 2004. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200:459.
27. Kontoyiannis, D. and Kollias, G. 2000. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol. 30:2038.
28. Aringer, M. and Smolen, J. 2008. The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res. Ther. 10:202.
29. Aringer, M., Steiner, G., Graninger, W., Höfler, E., Steiner, C., and Smolen, J. 2007. Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 56:274-279.
30. Koutouzov, S., Mathian, A. and Dalloul, A. 2006. Type-I interferons and systemic lupus erythematosus. Autoimmun. Rev. 5:554.
31. Niewold, T. B. 2011. Interferon alpha as a primary pathogenic factor in human lupus. J. Interferon Cytokine Res. 31:887.
32. Reeves, W. H., Lee, P. Y., Weinstein, J. S., Satoh, M. and Lu, L. 2009. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends in immunology 30:455.
33. Gaipl, U. S., Voll, R. E., Sheriff, A., Franz, S., Kalden, J. R. and Herrmann, M. 2005. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun. Rev. 4:189.
34. Cohen, P. L., Caricchio, R., Abraham, V. et al. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196:135.
35. Bygrave, A., Rose, K., Cortes-Hernandez, J. et al. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2:E243.
36. Rhodes, B. and Vyse, T. J. 2007. General aspects of the genetics of SLE. Autoimmunity 40:550.
37. Meyers, J. H., Chakravarti, S., Schlesinger, D. et al. 2005. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat. Immunol. 6:455.
38. Wandstrat, A. and Wakeland, E. 2001. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2:802.
39. Hu, B., Jennings, J. H., Sonstein, J. et al. 2004. Resident murine alveolar and peritoneal macrophages differ in adhesion of apoptotic thymocytes. Am. J. Respir. Cell Mol. Biol. 30:687.
40. Rahman, Z. S. M., Shao, W.-H., Khan, T. N., Zhen, Y. and Cohen, P. L. 2010. Impaired apoptotic cell clearance in the germinal center by Mer-deficient tingible body macrophages leads to enhanced antibody-forming cell and germinal center responses. J. Immunol. 185:5859.
41. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:745.
42. Chen, X. and Oppenheim, J. J. 2011. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett.:1.
43. Williams, E., Gadola, S. and Edwards, C. 2009. Anti-TNF-induced lupus. Rheumatology (Oxford) 48:716.
44. Aringer, M. and Smolen, J. S. 2009. TNF inhibition in SLE: where do we stand? Lupus 18:5.
45. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
46. Satoh, M., Weintraub, J. P., Yoshida, H. et al. 2000. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J. Immunol. 165:1036.
47. Rahman, A. and Isenberg, D. A. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358:929.